Catalyst Wire Dossier Catalyst Wire Dossier

OT-551 Eye Drops

OT-551 · Othera Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OT-551 Eye Drops, covering 2008-04-02 to 2008-04-02. Get the full timeline:

Most recent: Clinical Trial Update: Study of OT-551 Eye Drops to Prevent or Delay Progression of Nuclear Cataracts Following Vitreous Removal [Phase 2]

See pricing